LEP and type 2 diabetes mellitus: The limitations were that the study involved a small group of homogenous participants that decreased the statistical power and generalizability to other populations, a cross-sectional design that precluded causal assessment, non-inclusion of some clinical characteristics (e.g., dietary assessment, sleep pattern), and non-inclusion of other adipocytokines with potential importance in T2D (e.g., leptin).